Aggarwal V, et al. - Researchers planned this study to describe capsule endoscopy (CE) findings in small-bowel Crohn’s disease (CD) patients in clinical remission compared with fecal biomarkers and standard clinical tools to determine mucosal remission and predict relapses. Evaluated by CE and fecal biomarkers, many had ongoing mucosal inflammation in small-bowel CD patients in clinical remission. During medium-term follow-up, only a minority developed a clinical flare. These findings suggested that in monitoring small-bowel CD progress, CE and fecal biomarkers were useful.